← Open Payments lookup

MICHELLE TAYLOR: Open Payments

NPI 1023469244 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,004 in 152 payments from 25 companies in 2025. Trend: 2023 $2,846 · 2024 $2,648 · 2025 $3,004

Food & beverage: $2,871Education: $133
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP26$611
United Therapeutics Corporation11$236
Grifols USA, LLC10$232
GlaxoSmithKline, LLC.19$221
Actelion Pharmaceuticals US, Inc.6$193
Verona Pharma, Inc.12$192
Boehringer Ingelheim Pharmaceuticals, Inc.10$182
Merck Sharp & Dohme LLC7$173
GENZYME CORPORATION10$167
ANI Pharmaceuticals, Inc.7$139

Products named: DUPIXENT, FASENRA, Prolastin-C Liquid, TEZSPIRE, Ohtuvayre, Tyvaso, PURIFIED CORTROPHIN GEL, NUCALA.

Industry payments across MS — which companies pay providers there.